Literature DB >> 29421578

Long non-coding RNA ENST01108 promotes carcinogenesis of glioma by acting as a molecular sponge to modulate miR-489.

Dawei Xu1, Ruihua Liu2, Lei Meng2, Yi Zhang3, Guangjian Lu4, Pengju Ma2.   

Abstract

Gliomas are the most common primary malignant tumor in the adult central nervous system with poor prognosis. Exploring novel biomarkers and elucidating underlying molecular mechanisms to provide effective therapeutic methods is in an urgent need. Long noncoding RNAs (lncRNAs) is involved in various human diseases including cancer. However, studies on lncRNAs and gliomas are limited. In this study, we explored the expression patterns of lncRNAs in 4 pairs of glioma samples and adjacent normal tissues via microarray and chose the most up-regulated lncRNA ENST01108 (ENST01108) to further verify its oncogenic role in glioma. Clinical data suggest that ENST01108 is closely associated with the malignant status in glioma. In vitro experiment demonstrated that overexpression of ENST01108 promoted glioma cell proliferation, migration, invasion, EMT process and survival, while knockdown of ENST01108 has an opposite effect, indicating that ENST01108 serves as an oncogenic property in glioma carcinogenesis. Further, we identified miR-489 as a direct target of ENST01108 and ENST01108 negatively regulate miR-489 by act as a sponge. SIK1 is verified as the direct target of miR-489 and it is negatively regulated by miR-489. ENST01108 also positively regulate SIKI and it promotes SIKI expression by suppressing miR-489. Taken together, the reciprocal repression of ENST011081 and miR-489 may be served as potential targets for cancer therapeutics in glioma.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ENST01108; Glioma; SIK1; miR-489

Mesh:

Substances:

Year:  2018        PMID: 29421578     DOI: 10.1016/j.biopha.2018.01.126

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  LncRNA MEG3 Reduces Hippocampal Neuron Apoptosis via the PI3K/AKT/mTOR Pathway in a Rat Model of Temporal Lobe Epilepsy.

Authors:  Hongyan Zhang; Jiuyun Tao; ShuXia Zhang; XinXin Lv
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-28       Impact factor: 2.570

2.  Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasets.

Authors:  Yuanyong Wang; Tong Lu; Yang Wo; Xiao Sun; Shicheng Li; Shuncheng Miao; Yanting Dong; Xiaoliang Leng; Wenjie Jiao
Journal:  PeerJ       Date:  2019-04-23       Impact factor: 2.984

3.  Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis.

Authors:  Zihao Wang; Lu Gao; Xiaopeng Guo; Chenzhe Feng; Kan Deng; Wei Lian; Bing Xing
Journal:  Oncol Rep       Date:  2019-05-28       Impact factor: 3.906

4.  miR‑489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways.

Authors:  Wei Wang; Luyang Zhang; Wei Gao; Dongyong Zhang; Zilong Zhao; Yijun Bao
Journal:  Oncol Rep       Date:  2019-10-22       Impact factor: 3.906

5.  Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy.

Authors:  Houshi Xu; Qingwei Zhu; Lan Tang; Junkun Jiang; Huiwen Yuan; Anke Zhang; Meiqing Lou
Journal:  Cancer Cell Int       Date:  2021-02-12       Impact factor: 5.722

6.  Expression of miR-221 and miR-489 in breast cancer patients and their relationship with prognosis.

Authors:  Fanfan Li
Journal:  Oncol Lett       Date:  2019-12-10       Impact factor: 2.967

Review 7.  The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis.

Authors:  Zicheng Sun; Qiwei Jiang; Jie Li; Jianping Guo
Journal:  Signal Transduct Target Ther       Date:  2020-08-12

8.  Interaction of BACH2 with FUS promotes malignant progression of glioma cells via the TSLNC8-miR-10b-5p-WWC3 pathway.

Authors:  Yang Yang; Xiaobai Liu; Jian Zheng; Yixue Xue; Libo Liu; Jun Ma; Ping Wang; Chunqing Yang; Di Wang; Lianqi Shao; Xuelei Ruan; Yunhui Liu
Journal:  Mol Oncol       Date:  2020-09-26       Impact factor: 7.449

9.  Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi-center study.

Authors:  Anke Zhang; Houshi Xu; Zeyu Zhang; Yibo Liu; Xiaying Han; Ling Yuan; Yunjia Ni; Shiqi Gao; Yuanzhi Xu; Sheng Chen; Junkun Jiang; Yike Chen; Xiaotao Zhang; Meiqing Lou; Jianmin Zhang
Journal:  CNS Neurosci Ther       Date:  2021-07-16       Impact factor: 5.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.